These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 21504142)
1. Drug to genome to drug: discovery of new antiplasmodial compounds. Beghyn TB; Charton J; Leroux F; Laconde G; Bourin A; Cos P; Maes L; Deprez B J Med Chem; 2011 May; 54(9):3222-40. PubMed ID: 21504142 [TBL] [Abstract][Full Text] [Related]
2. Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds. Beghyn TB; Charton J; Leroux F; Henninot A; Reboule I; Cos P; Maes L; Deprez B J Med Chem; 2012 Feb; 55(3):1274-86. PubMed ID: 22204607 [TBL] [Abstract][Full Text] [Related]
3. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum. Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-beta-carbolines as a new class of antimalarial agents. Gupta L; Srivastava K; Singh S; Puri SK; Chauhan PM Bioorg Med Chem Lett; 2008 Jun; 18(11):3306-9. PubMed ID: 18442907 [TBL] [Abstract][Full Text] [Related]
5. Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro. Musonda CC; Little S; Yardley V; Chibale K Bioorg Med Chem Lett; 2007 Sep; 17(17):4733-6. PubMed ID: 17644333 [TBL] [Abstract][Full Text] [Related]
6. Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Sung BJ; Hwang KY; Jeon YH; Lee JI; Heo YS; Kim JH; Moon J; Yoon JM; Hyun YL; Kim E; Eum SJ; Park SY; Lee JO; Lee TG; Ro S; Cho JM Nature; 2003 Sep; 425(6953):98-102. PubMed ID: 12955149 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors. Ahmed NS; Gary BD; Tinsley HN; Piazza GA; Laufer S; Abadi AH Arch Pharm (Weinheim); 2011 Mar; 344(3):149-57. PubMed ID: 21384413 [TBL] [Abstract][Full Text] [Related]
8. Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives. Ahmed NS; Ali AH; El-Nashar SM; Gary BD; Fajardo AM; Tinsley HN; Piazza GA; Negri M; Abadi AH Eur J Med Chem; 2012 Nov; 57():329-43. PubMed ID: 23117589 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains. Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433 [TBL] [Abstract][Full Text] [Related]
10. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR. Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829 [TBL] [Abstract][Full Text] [Related]
11. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 1-amino-6-halo-β-carbolines as antimalarial and antiprion agents. Thompson MJ; Louth JC; Little SM; Jackson MP; Boursereau Y; Chen B; Coldham I ChemMedChem; 2012 Apr; 7(4):578-86. PubMed ID: 22275299 [TBL] [Abstract][Full Text] [Related]
13. Design of novel β-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors. El-Gamil DS; Ahmed NS; Gary BD; Piazza GA; Engel M; Hartmann RW; Abadi AH Arch Pharm (Weinheim); 2013 Jan; 346(1):23-33. PubMed ID: 23307609 [TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide-specific phosphodiesterases of Plasmodium falciparum: PfPDEalpha, a non-essential cGMP-specific PDE that is an integral membrane protein. Wentzinger L; Bopp S; Tenor H; Klar J; Brun R; Beck HP; Seebeck T Int J Parasitol; 2008 Dec; 38(14):1625-37. PubMed ID: 18590734 [TBL] [Abstract][Full Text] [Related]
15. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity. Gupta R; Kumar G; Kumar RS Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463 [TBL] [Abstract][Full Text] [Related]
16. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi. Kunz S; Oberholzer M; Seebeck T FEBS J; 2005 Dec; 272(24):6412-22. PubMed ID: 16336277 [TBL] [Abstract][Full Text] [Related]
17. Antiplasmodial activities of 4-aminoquinoline-statine compounds. Vaiana N; Marzahn M; Parapini S; Liu P; Dell'Agli M; Pancotti A; Sangiovanni E; Basilico N; Bosisio E; Dunn BM; Taramelli D; Romeo S Bioorg Med Chem Lett; 2012 Sep; 22(18):5915-8. PubMed ID: 22884991 [TBL] [Abstract][Full Text] [Related]